
Patent Law Weblog
recent posts
- Retired Judges File Amicus Brief in Support of Judge Newman
- Hikma v. Amarin at the Supreme Court: The Parties’ Opening Briefs
- Teva Pharmaceuticals International v. Eli Lilly & Co. (Fed. Cir. 2026)
- USPTO Extends Artificial Intelligence Search Automated Pilot Program (ASAP!)
- USPTO Announces That It Has Turned the Corner on Unexamined Application Backlog
about
Month: December 2017
-
Strafford will be offering a webcast entitled "After-Final Practice: Navigating PTO Options to Compact Patent Prosecution — Utilizing After-Final Consideration Pilot 2.0, Pre-Appeal Conference and More" on January 9, 2018 from 1:00 to 2:30 pm (EST). Justin J. Cassell of Workman Nydegger and Mandy J. Song of Finnegan Henderson Farabow Garrett & Dunner will provide…
-
The U.S. Patent and Trademark Office will be holding a customer partnership meeting of Technology Center 2600 from 8:30 am to 4:00 pm (ET) on January 17, 2018. The agenda for the meeting is as follows: • Morning Network — 8:30 – 9:00 am• Introductions — TC Contacts for Procedural Issue — 9:00 – 9:30…
-
Strafford will be offering a webcast entitled "Patent Term Adjustments and Extensions: Leveraging Recent Decisions and USPTO Rule Changes" on January 11, 2018 from 1:00 to 2:30 pm (EST). Thomas L. Irving, Jill K. MacAlpine, and Charles E. Van Horn of Finnegan Henderson Farabow Garrett & Dunner will provide guidance to IP counsel for calculating…
-
Patent Docs readers are invited to attend a webinar on "Sequence Listings and Patent Applications" that will take place on January 9, 2018 from 1:00 to 2:30 pm (ET). Suzannah K. Sundby of Canady + Lortz LLP and Carl Oppedahl of Oppedahl Patent Law Firm LLC will explain how to prepare and e-file computer-readable sequence…
-
Strafford will be offering a webcast entitled "Patent Drafting for Machine Learning: Structural Claim Limitations, Avoiding 101 or 112 Rejections" on January 4, 2018 from 1:00 to 2:30 pm (EST). Gregory Rabin of Schwegman Lundberg & Woessner and Michael D. Stein of Baker & Hostetler will provide guidance to patent practitioners on overcoming challenges when…
-
By John Wizeman* and Anthony D. Sabatelli** — Clarity on patent subject matter eligibility is still being sought five years after Mayo [1] and three years after Alice [2]. Further adding to the confusion is the fact that discoveries in diagnostics, despite their apparent importance to the biomedical sciences, have been repeatedly determined as ineligible…
-
By Kevin E. Noonan – The Patent Trial and Appeal Board was seemingly sufficiently vexed over the question of whether the St. Mohawk Indian Tribe was entitled to have the Board dismiss, on grounds of sovereign immunity, inter partes reviews on patents the Tribe licensed from Allergan (see "Mohawk Nation Exercises Sovereign Immunity in Inter Partes…
-
By Donald Zuhn — PricewaterhouseCoopers (PwC) and CB Insight recently released the results of its US MoneyTreeTM Report on U.S. venture funding for the third quarter of 2017. The report indicates that venture capitalists invested $19.0 billion in 1,207 deals in the third quarter, with the number of dollars and deals remaining steady after $18.9…
-
By Donald Zuhn — Last week, in Ni-Q, LLC v. Prolacta Bioscience, Inc., District Judge Michael H. Simon of the U.S. District Court for the District of Oregon denied a motion for judgment on the pleadings under Rule 12(c) of the Federal Rules of Civil Procedure filed by Plaintiff Ni-Q that the claims of U.S.…
-
December 12, 2017 – "Capitalizing on Changes in Patent Law" (Practising Law Institute) – 1:00 to 2:00 pm (Eastern) December 12, 2017 – "Written Description in the Life Sciences after Amgen v. Sanofi" (Intellectual Property Owners Association) – 2:00 to 3:00 pm (ET) December 13, 2017 – "Nuts & Bolts of the Federal Circuit's Rules"…